Latest News - Thermo Fisher Scientific
Top Corporates Hub
Thermo Fisher Scientific
3 Reasons TMO is Risky and 1 Stock to Buy Instead
18.06.2026 10:53
Over the last six months, Thermo Fisher’s shares have sunk to $464.50, producing a disappointing 17.4% loss - a stark contrast to the S&P 500’s 10.9% gain. This might have investors contemplating their next move.
Avantor (AVTR) Gets Underperform Rating From Wolfe Research
17.06.2026 09:59
Avantor, Inc. (NYSE:AVTR) is one of the 10 Best Stocks to Buy Under $10. On June 1, Wolfe Research initiated coverage on Avantor, Inc. (NYSE:AVTR), giving the stock an Underperform rating and setting the price target at $7. The research firm noted that the company has seen multiple years of growth and margin challenges. Revenue […]
Piper Sandler Initiates Coverage of Thermo Fisher Scientific (TMO) with a Neutral View
16.06.2026 02:04
Thermo Fisher Scientific Inc. (NYSE:TMO) is included among the 14 Best S&P 500 Stocks to Buy Now According to Analysts. Thermo Fisher Scientific Inc. (NYSE:TMO) provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in North America, Europe, Asia-Pacific, and internationally. On June 11, Piper Sandler initiated coverage of Thermo […]
Piper Sandler Initiates Coverage of Thermo Fisher Scientific (TMO) with a Neutral View
16.06.2026 02:04
Thermo Fisher Scientific Inc. (NYSE:TMO) is included among the 14 Best S&P 500 Stocks to Buy Now According to Analysts. Thermo Fisher Scientific Inc. (NYSE:TMO) provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in North America, Europe, Asia-Pacific, and internationally. On June 11, Piper Sandler initiated coverage of Thermo […]
Here's How Innovation Fuels Globus Medical's Growth Momentum
15.06.2026 14:32
GMED is accelerating product launches, FDA clearances and R&D investment, reinforcing its strategy to expand spine and orthopedic workflows.
Why HSBC Turned More Cautious on Thermo Fisher Scientific (TMO)
09.06.2026 02:50
Thermo Fisher Scientific Inc. (NYSE:TMO) is included among the Billionaire Ken Fisher’s Top 11 Dividend Stock Picks. On June 3, HSBC downgraded Thermo Fisher Scientific Inc. (NYSE:TMO) to Hold from Buy. It also lowered its price target on the stock to $540 from $670.The firm said Thermo Fisher’s goal of returning to 7% growth beyond […]
The Bull Case For Thermo Fisher Scientific (TMO) Could Change Following AI-Enhanced Orbitrap Drug Discovery Launches – Learn Why
05.06.2026 00:17
In late May 2026, Thermo Fisher Scientific showcased its new Thermo Scientific Orbitrap Tribrid Apex and Orbitrap Excedion mass spectrometers at the ASMS Conference, highlighting faster, more sensitive multiomics and complex drug development analysis alongside AI-enabled software and its Olink proteomics platform. By pairing these Orbitrap systems with recent AI-focused software acquisitions and expanded bioanalytical labs in Sweden, Thermo Fisher is deepening its role across the entire drug...
Jim Cramer on Danaher: “At These Prices, It’s Clearly Overvalued”
04.06.2026 10:58
Danaher Corporation (NYSE:DHR) was among the stocks Jim Cramer talked about as he discussed the recent rally in several AI-related stocks. Cramer compared the company’s valuation to its organic growth, as he remarked: Danaher, once among the most revered companies in the entire market, still trades at 21 times earnings. But at these prices, it’s […]
Is Thermo Fisher Scientific (TMO) Pricing Look Interesting After Recent Share Price Swings
02.06.2026 11:16
If you are wondering whether Thermo Fisher Scientific at around US$494 per share looks attractively priced or stretched, the starting point is to understand what the current market is implying about its future. The stock has been volatile recently, with a 10.2% gain over the past week, a 5.3% gain over the past month, a decline of 16.6% year to date, and a 25.1% gain over the past year, which together suggest shifting views on its prospects and risk profile. Recent headlines have focused on...
Laboratory Equipment Services Market by Service Type, Service Provider, Equipment Type, Contract Type - Global Forecast to 2030
02.06.2026 08:21
The global laboratory equipment services market is set to soar, reaching USD 35.4 billion by 2030, expanding from USD 18 billion in 2025, with a CAGR of 14.5%. This growth is spurred by increased R&D investments, higher healthcare spending, and technological advancements. The Asia-Pacific region leads with the highest CAGR, fueled by robust infrastructure growth in countries like China and India. Dominating segments include analytical equipment and the comprehensive Gold Support Plan. Key driver
Wolfe Research Assumes Thermo Fisher Scientific at Outperform, Announces Price Target of $535
02.06.2026 07:27
Wolfe Research analyst Mike Polark assumes Thermo Fisher Scientific (NYSE:TMO) with a Outperform rating and announces Price Target of $535.
3 Cash-Producing Stocks We Steer Clear Of
29.05.2026 15:36
A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand.
Thermo Fisher (TMO) Surges 6.8%: Is This an Indication of Further Gains?
29.05.2026 13:23
Thermo Fisher (TMO) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the near term.
Is QGEN Stock a Hold After the 2026 Outlook Cut and Q1 Miss?
29.05.2026 13:16
QIAGEN cuts its 2026 growth outlook after a Q1 miss, but margins, cash flow and a debt-free balance sheet could steady the narrative.
Thermo Fisher Scientific Unveils Next-generation Innovations at ASMS 2026 to Accelerate the Path from Drug Discovery to New Therapies
28.05.2026 12:00
WALTHAM, Mass., May 28, 2026--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced the Thermo Scientific™ Orbitrap™ Tribrid™ Apex and Thermo Scientific™ Orbitrap™ Excedion™ mass spectrometers will be showcased at the American Society for Mass Spectrometry (ASMS) Conference. As scientific discovery expands into more complex applications—from advanced proteomics and multiomics to biologics and genetic medicines—researchers and drug developers face increas
Is Thermo Fisher Scientific Inc. (TMO) a Buy as RBC Restarts Coverage With Sector Perform Rating?
28.05.2026 11:48
We recently compiled a list of the 10 Most Widely Held Stocks by Individuals in 2026. Thermo Fisher Scientific Inc. (NYSE:TMO) is among the most widely held stocks by individuals. TheFly reported on May 14 that RBC Capital restarted coverage of TMO with a Sector Perform rating and assigned a $490 price objective. The firm pointed […]
[Latest] Global Bioprocess Automation Software Market Size/Share Worth USD 6.19 Billion by 2035 at a 14 CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)
26.05.2026 04:30
[220+ Pages Latest Report] According to a market research study published by Healthcare Foresights, the demand analysis of Global Bioprocess Automation Software Market size & share revenue was valued at approximately USD 1.67 Billion in 2025 and is expected to reach USD 1.90 Billion in 2026 and is expected to reach around USD 6.19 Billion by 2035, at a CAGR of 14 between 2026 and 2035. The key market players listed in the report with their sales, revenues and strategies are Xeris Pharmaceuticals
Thermo Fisher Scientific Highlights Industry Leadership, Growth Outlook and Long-Term Value Creation at 2026 Investor Day
20.05.2026 12:30
WALTHAM, Mass., May 20, 2026--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, hosted its Investor Day today. Chairman and Chief Executive Officer Marc N. Casper and members of the senior leadership team highlighted the company’s industry leadership and the essential role of its best-in-class products and services to customers around the world.
1 S&P 500 Stock with Promising Prospects and 2 We Ignore
20.05.2026 09:24
The S&P 500 (^GSPC) is home to the biggest and most well-known companies in the market, making it a go-to index for investors seeking stability. But not all large-cap stocks are created equal - some are struggling with slowing growth, declining margins, or increased competition.
Global Cell Culture Media Market Outlook 2026-2036: Biologics Manufacturing and Cell Therapy Expansion Accelerate Growth for Avantor, Thermo Fisher Scientific, and Lonza Group AG
19.05.2026 10:39
According to the latest market analysis by Future Market Insights (FMI), the global Cell Culture Media Market is projected to grow from USD 3.7 billion in 2026 to USD 7.1 billion by 2036, expanding at a CAGR of 6.6% during the forecast period. Market growth is being driven by rising biologics production, expanding cell and gene therapy pipelines, increasing adoption of serum-free formulations, and growing demand for reproducible, GMP-grade manufacturing inputs across regulated biopharmaceutical